Literature DB >> 17961614

Injecting drug use is associated with HIV risk perception among Mexican Americans in the Rio Grande Valley of South Texas, USA.

E J Essien1, G O Ogungbade, D Ward, M E Fernandez-Esquer, C R Smith, L Holmes.   

Abstract

OBJECTIVES: Injecting drug use (IDU) remains an actual risk variable in human immunodeficiency virus (HIV) infection in most ethnic populations, and the association between actual risk and individual perception of HIV risk varies across studies and samples. This study aimed to examine the relationship between IDU and HIV risk perception among Mexican Americans residing in Rio Grande Valley, South Texas. STUDY
DESIGN: A cross-sectional study of IDU as a predictor of HIV risk perception.
METHODS: Two hundred and seventy-five participants [IDUs 11.9%, non-IDUs 88.1%] were assessed for an association between IDU and individual risk perception for HIV infection, as well as history of drug use and HIV risk perception, using Chi-squared statistic for independence and a logistic regression model for the prevalence odds ratio (POR).
RESULTS: There was no statistically significant difference between IDUs and non-IDUs with respect to the sociodemographic variables, except for income and gender (P<0.05). The results indicated a statistically significant decrease in HIV risk perception among IDUs compared with non-IDUs, after adjustment for age, gender, sexual preference, history of drug use and marital status [POR 0.26, 95% confidence intervals (CI) 0.11-0.65]. Likewise, history of drug use was associated with decreased HIV risk perception (POR 0.44, 95% CI 0.22-0.98).
CONCLUSIONS: These results suggest an inverse correlation between actual risk of HIV infection, such as IDU, and HIV risk perception. Therefore, assessment of HIV risk perception, which is a significant determinant of behaviour change, is essential to reduce the prevalence of HIV infection in the targeted population.

Entities:  

Mesh:

Year:  2007        PMID: 17961614      PMCID: PMC2268617          DOI: 10.1016/j.puhe.2007.07.023

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  13 in total

1.  Drug-scene roles and HIV risk among Puerto Rican injection drug users in East Harlem, New York and Bayamón, Puerto Rico.

Authors:  Samuel R Friedman; Sung-Yeon Kang; Sherry Deren; Rafaela Robles; Hector M Colón; Jonny Andia; Denise Oliver-Velez; Ann Finlinson
Journal:  J Psychoactive Drugs       Date:  2002 Oct-Dec

2.  HIV incidence among high-risk Puerto Rican drug users: a comparison of East Harlem, New York, and Bayamón, Puerto Rico.

Authors:  Sherry Deren; Sung-Yeon Kang; Hector M Colón; Jonny F Andia; Rafaela R Robles
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-15       Impact factor: 3.731

Review 3.  Racial/ethnic disparities in injection drug use in large US metropolitan areas.

Authors:  Hannah Cooper; Samuel R Friedman; Barbara Tempalski; Risa Friedman; Marie Keem
Journal:  Ann Epidemiol       Date:  2005-05       Impact factor: 3.797

4.  Keeping it together: stigma, response, and perception of risk in relationships between drug injectors and crack smokers, and other community residents.

Authors:  P Mateu-Gelabert; C Maslow; P L Flom; M Sandoval; M Bolyard; S R Friedman
Journal:  AIDS Care       Date:  2005-10

5.  Prevalence and determinants of HIV infection in South India: a heterogeneous, rural epidemic.

Authors:  Marissa L Becker; B M Ramesh; Reynold G Washington; Shiva Halli; James F Blanchard; Stephen Moses
Journal:  AIDS       Date:  2007-03-30       Impact factor: 4.177

6.  AIDS knowledge, perception of risk, and behaviors among female sex partners of injection drug users.

Authors:  N H Corby; R J Wolitski; S Thornton-Johnson; W M Tanner
Journal:  AIDS Educ Prev       Date:  1991

Review 7.  Substance use and risky sexual behavior for exposure to HIV. Issues in methodology, interpretation, and prevention.

Authors:  B C Leigh; R Stall
Journal:  Am Psychol       Date:  1993-10

Review 8.  Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.

Authors:  Antonio L Estrada
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

9.  HIV risk profile of drug-using women who have sex with women in 19 United States cities.

Authors:  A H Kral; J Lorvick; R N Bluthenthal; J K Watters
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-11-01

10.  Racial differences in sexual behaviors related to AIDS in a nineteen-city sample of street-recruited drug injectors. NADR Consortium.

Authors:  S R Friedman; P A Young; F R Snyder; V Shorty; A Jones; A L Estrada
Journal:  AIDS Educ Prev       Date:  1993
View more
  5 in total

1.  Perceived risk of HIV infection among deported male injection drug users in Tijuana, Mexico.

Authors:  Miguel Pinedo; José Luis Burgos; Angela M Robertson; Alicia Vera; Remedios Lozada; Victoria D Ojeda
Journal:  Glob Public Health       Date:  2014-03-21

2.  Individual and socio-environmental factors associated with unsafe injection practices among young adult injection drug users in San Diego.

Authors:  Fátima Muñoz; José Luis Burgos; Jazmine Cuevas-Mota; Eyasu Teshale; Richard S Garfein
Journal:  AIDS Behav       Date:  2015-01

3.  Racial/ethnic differences in the rates and correlates of HIV risk behaviors among drug abusers.

Authors:  Audrey J Brooks; Yuliya Lokhnygina; Christina S Meade; Jennifer Sharpe Potter; Donald A Calsyn; Shelly F Greenfield
Journal:  Am J Addict       Date:  2013 Mar-Apr

4.  Correlates of perceived risk of HIV infection among persons who inject drugs in Tijuana, Baja California, Mexico.

Authors:  Richard F Armenta; Daniela Abramovitz; Remedios Lozada; Alicia Vera; Richard S Garfein; Carlos Magis-Rodríguez; Steffanie A Strathdee
Journal:  Salud Publica Mex       Date:  2015

5.  Should associations between HIV-related risk perceptions and behaviors or intentions be positive or negative?

Authors:  Hiyi Tsui; Joseph T F Lau; Weina Xiang; Jing Gu; Zixin Wang
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.